Go Pro

Paradigm Capital Management Inc. NY Makes New $5.31 Million Investment in Addus HomeCare Corporation $ADUS

Addus HomeCare logo with Healthcare background
Image from MarketBeat Media, LLC.

Paradigm Capital Management Inc. NY bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 52,870 shares of the company's stock, valued at approximately $5,312,000. Paradigm Capital Management Inc. NY owned 0.28% of Addus HomeCare as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Global Retirement Partners LLC grew its holdings in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC raised its holdings in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company's stock valued at $28,000 after buying an additional 136 shares during the period. NFJ Investment Group LLC acquired a new position in Addus HomeCare in the second quarter valued at about $29,000. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare in the fourth quarter valued at about $29,000. Finally, Arax Advisory Partners boosted its stake in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the company's stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ADUS. Weiss Ratings upgraded shares of Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Royal Bank Of Canada upped their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Barclays increased their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an "underweight" rating in a research report on Wednesday, July 8th. Citigroup reiterated a "market outperform" rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Citizens Jmp reissued a "market outperform" rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $130.88.

Read Our Latest Report on Addus HomeCare

Addus HomeCare Stock Up 0.0%

Shares of NASDAQ:ADUS opened at $120.82 on Tuesday. The firm has a market capitalization of $2.26 billion, a PE ratio of 21.20, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The firm's 50-day moving average is $109.99 and its two-hundred day moving average is $102.58.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.49 earnings per share. Analysts predict that Addus HomeCare Corporation will post 6.29 EPS for the current year.

About Addus HomeCare

(Free Report)

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines